Active Power, Inc. (NASDAQ: ACPW), has been invited to present at the 27th Annual ROTH Conference being held March 8-11, 2015, at the Ritz Carlton in Dana Point, Calif. On Monday shares of Active Power Inc. (NASDAQ:ACPW) closed at $2.13. Company’s sales growth for last 5 years was 7.50% and EPS growth for next 5 years is recorded as 20.00%.
BIND Therapeutics, Inc. (NASDAQ:BIND), announced it will host a conference call and live audio webcast on March 11, 2015, at 8:30 a.m. ET to report fourth quarter and year-end 2014 financial results. BIND Therapeutics, Inc. (NASDAQ:BIND) in last trading activity increased 0.33% to close at $6.08. Company weekly performance is -0.49% while its quarterly performance stands at -9.39%. BIND Therapeutics, Inc. (NASDAQ:BIND) is -57.57% away from its 52 week high.
DragonWave Inc. (NASDAQ:DRWI) announced entry into Nokia’s newly formed MicroWave Backhaul EcoSystem. DragonWave is continuing its longstanding partnering with Nokia, which was formed four years ago, and was strengthened in 2012 through DragonWave’s purchase of the Nokia microwave business unit. The two companies have over 50 active customers.On last trading day DragonWave Inc. (NASDAQ:DRWI) fell -1.86% to close at $0.87. Its volatility for the week is 6.32% while volatility for the month is 5.61%. DRWI’s sales growth for past 5 years was 15.80% and its EPS growth for past 5 years was -31.60%. DragonWave Inc. (NASDAQ:DRWI) monthly performance is 3.87%.
On 28 February, LyondellBasell Industries N.V. (NYSE:LYB) announced the pricing of its public offering of $1 billion aggregate principal amount of 4.625% Senior Notes due 2055. The offering is expected to close on Mar 5, 2015, on meeting the customary closing conditions. LyondellBasell Industries N.V. (NYSE:LYB) has 0.50% insider ownership while its institutional ownership stands at 77.40%. In last trading activity company’s stock closed at $86.10.
Endocyte Inc. (NASDAQ:ECYT) reported a loss of $8.1 million in its fourth quarter. The West Lafayette, Indiana-based company said it had a loss of 19 cents per share. The results surpassed Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share. On last trading day Endocyte, Inc. (NASDAQ:ECYT) increased 4.31% to close at $6.05. Its volatility for the week is 5.92% while volatility for the month is 4.90%. ECYT’s sales growth for past 5 years was 164.60% and its EPS growth for past 5 years was 1.20%. Endocyte, Inc. (NASDAQ:ECYT) monthly performance is 11.83%.